
ALC Stock Forecast & Price Target
ALC Analyst Ratings
Bulls say
Alcon is a global leader in the visioncare industry, with a strong portfolio of products that include contact lenses, lenscare solutions, and a wide range of ocular health products. The company's recent spin-off from Novartis provides a lucrative opportunity to investors as Alcon continues to launch innovative products in high-growth categories. Combined with solid operating margin improvement and a strong product pipeline, we believe Alcon is well positioned for sustained mid-single digit revenue growth and double-digit EPS growth.
Bears say
Alcon is currently experiencing some challenges, as their top-line growth projections are lower than what was expected. Although the company is making strides in the surgical segment, they face tough competition and challenges in the contact lens market. Additionally, there are concerns about the impact of tariffs and potential refunds on their financials. However, the company has a strong installed base and is making strategic moves, which may drive growth and margin improvements in the future.
This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.
ALC Analyst Forecast & Price Prediction
Start investing in ALC
Order type
Buy in
Order amount
Est. shares
0 shares